<unk>  is a<unk> globulin G antidote that is FDA approved for the treatment of potentially life-threatening<unk>  toxicity or overdose.   Common adverse reactions include hypokalemia, exacerbation of low cardiac output, and rapid ventricular response in patients with atrial fibrillation.
Digoxin immune fab
Niacin extended release
Beta blockers
Third degree AV block surgery
Second degree AV block surgery
Premature ventricular contraction ablation
Pericardiectomy
Colestilan